What top creators are saying about BillionToOne, Inc.(BTO)
A molecular diagnostics company specializing in prenatal genetic testing and liquid biopsy oncology tests using proprietary Quantitative Counting Templates.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about BillionToOne, Inc. in the last 30 days yet.
Top creators covering BillionToOne, Inc. (BTO)
The 1 sources with the most insights about BillionToOne, Inc. on Kazuha.
Latest insights about BillionToOne, Inc. (BTO)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, April 6, 2026
The company is successfully scaling from a 20% market share in prenatal testing to a broad oncology powerhouse, with a high-growth trajectory and upcoming MRD test launch for a larger TAM.
Monday, April 6, 2026
The company is successfully scaling from a 20% market share in prenatal testing to a broad oncology powerhouse, with a high-growth trajectory and upcoming MRD test launch for a larger TAM.
Frequently asked
Which podcasters and creators cover BillionToOne, Inc. (BTO) the most?
The most active sources covering BillionToOne, Inc. (BTO) on Kazuha are Y Combinator. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about BillionToOne, Inc. (BTO) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about BillionToOne, Inc. (BTO) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.